103 related articles for article (PubMed ID: 20435171)
1. Virus-host cell interactions in vaccine production cell lines infected with different human influenza A virus variants: a proteomic approach.
Vester D; Rapp E; Kluge S; Genzel Y; Reichl U
J Proteomics; 2010 Aug; 73(9):1656-69. PubMed ID: 20435171
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of cellular proteome alterations in human influenza A virus-infected mammalian cell lines.
Vester D; Rapp E; Gade D; Genzel Y; Reichl U
Proteomics; 2009 Jun; 9(12):3316-27. PubMed ID: 19504497
[TBL] [Abstract][Full Text] [Related]
3. Differential activation of host cell signalling pathways through infection with two variants of influenza A/Puerto Rico/8/34 (H1N1) in MDCK cells.
Heynisch B; Frensing T; Heinze K; Seitz C; Genzel Y; Reichl U
Vaccine; 2010 Nov; 28(51):8210-8. PubMed ID: 20691654
[TBL] [Abstract][Full Text] [Related]
4. Use of MDCK cells for production of live attenuated influenza vaccine.
Liu J; Shi X; Schwartz R; Kemble G
Vaccine; 2009 Oct; 27(46):6460-3. PubMed ID: 19559113
[TBL] [Abstract][Full Text] [Related]
5. Proteome analysis of virus-host cell interaction: rabies virus replication in Vero cells in two different media.
Kluge S; Rourou S; Vester D; Majoul S; Benndorf D; Genzel Y; Rapp E; Kallel H; Reichl U
Appl Microbiol Biotechnol; 2013 Jun; 97(12):5493-506. PubMed ID: 23674149
[TBL] [Abstract][Full Text] [Related]
6. A cell-based backup to speed up pandemic influenza vaccine production.
Lee MS; Hu AY
Trends Microbiol; 2012 Mar; 20(3):103-5. PubMed ID: 22257962
[TBL] [Abstract][Full Text] [Related]
7. Subcellular proteomic analysis of human host cells infected with H3N2 swine influenza virus.
Wu X; Wang S; Yu Y; Zhang J; Sun Z; Yan Y; Zhou J
Proteomics; 2013 Nov; 13(22):3309-26. PubMed ID: 24115376
[TBL] [Abstract][Full Text] [Related]
8. MDCK cell line with inducible allele B NS1 expression propagates delNS1 influenza virus to high titres.
van Wielink R; Harmsen MM; Martens DE; Peeters BP; Wijffels RH; Moormann RJ
Vaccine; 2011 Sep; 29(40):6976-85. PubMed ID: 21787829
[TBL] [Abstract][Full Text] [Related]
9. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs.
Govorkova EA; Kodihalli S; Alymova IV; Fanget B; Webster RG
Dev Biol Stand; 1999; 98():39-51; discussion 73-4. PubMed ID: 10494958
[TBL] [Abstract][Full Text] [Related]
10. A Vero-cell-adapted vaccine donor strain of influenza A virus generated by serial passages.
Hu W; Zhang H; Han Q; Li L; Chen Y; Xia N; Chen Z; Shu Y; Xu K; Sun B
Vaccine; 2015 Jan; 33(2):374-81. PubMed ID: 25448099
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of influenza virus replication in Vero and MDCK cell lines.
Youil R; Su Q; Toner TJ; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Kiseleva I; Shaw AR; DiStefano D
J Virol Methods; 2004 Sep; 120(1):23-31. PubMed ID: 15234806
[TBL] [Abstract][Full Text] [Related]
12. High yields of influenza A virus in Madin-Darby canine kidney cells are promoted by an insufficient interferon-induced antiviral state.
Seitz C; Frensing T; Höper D; Kochs G; Reichl U
J Gen Virol; 2010 Jul; 91(Pt 7):1754-63. PubMed ID: 20357039
[TBL] [Abstract][Full Text] [Related]
13. Enhanced production of enveloped viruses in BST-2-deficient cell lines.
Yi E; Oh J; Giao NQ; Oh S; Park SH
Biotechnol Bioeng; 2017 Oct; 114(10):2289-2297. PubMed ID: 28498621
[TBL] [Abstract][Full Text] [Related]
14. A host susceptibility gene, DR1, facilitates influenza A virus replication by suppressing host innate immunity and enhancing viral RNA replication.
Hsu SF; Su WC; Jeng KS; Lai MM
J Virol; 2015 Apr; 89(7):3671-82. PubMed ID: 25589657
[TBL] [Abstract][Full Text] [Related]
15. Impact of defective interfering particles on virus replication and antiviral host response in cell culture-based influenza vaccine production.
Frensing T; Pflugmacher A; Bachmann M; Peschel B; Reichl U
Appl Microbiol Biotechnol; 2014 Nov; 98(21):8999-9008. PubMed ID: 25132064
[TBL] [Abstract][Full Text] [Related]
16. Continuous cell lines as a production system for influenza vaccines.
Genzel Y; Reichl U
Expert Rev Vaccines; 2009 Dec; 8(12):1681-92. PubMed ID: 19943763
[TBL] [Abstract][Full Text] [Related]
17. Quantification of the host response proteome after herpes simplex virus type 1 infection.
Berard AR; Coombs KM; Severini A
J Proteome Res; 2015 May; 14(5):2121-42. PubMed ID: 25815715
[TBL] [Abstract][Full Text] [Related]
18. The growth of attenuated influenza vaccine donor strains in continuous cell lines.
Audsley JM; Tannock GA
J Virol Methods; 2005 Feb; 123(2):187-93. PubMed ID: 15620401
[TBL] [Abstract][Full Text] [Related]
19. Distributed modeling of human influenza A virus-host cell interactions during vaccine production.
Müller T; Dürr R; Isken B; Schulze-Horsel J; Reichl U; Kienle A
Biotechnol Bioeng; 2013 Aug; 110(8):2252-66. PubMed ID: 23475474
[TBL] [Abstract][Full Text] [Related]
20. Adaptation of a Madin-Darby canine kidney cell line to suspension growth in serum-free media and comparison of its ability to produce avian influenza virus to Vero and BHK21 cell lines.
van Wielink R; Kant-Eenbergen HC; Harmsen MM; Martens DE; Wijffels RH; Coco-Martin JM
J Virol Methods; 2011 Jan; 171(1):53-60. PubMed ID: 20933017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
